Lin Lin, Cui Peng, Qiu Zhipeng, Wang Min, Yu Yingchao, Wang Jing, Sun Qian, Zhao Hairong
Health Examination Department, Affiliated Qingdao Hiser Hospital of Qingdao University, Qingdao, Shandong 266000, P.R. China.
Multidisciplinary Consultation Center, Affiliated Qingdao Hiser Hospital of Qingdao University, Qingdao, Shandong 266000, P.R. China.
Exp Ther Med. 2019 Mar;17(3):1855-1862. doi: 10.3892/etm.2018.7143. Epub 2018 Dec 28.
Hypertension is a very common cardiovascular disorder, however, the molecular mechanism underlying this disease remains poorly understood. Recently, an increasing number of studies have demonstrated that mitochondrial (mt)DNA mutations serve important roles in the pathogenesis of hypertension. The current study reported the clinical and molecular characterization of a Chinese family with maternally inherited hypertension (the penetrance of hypertension was 71.4%). In addition, the entire mitochondrial transfer (mt-t)RNA genomes was amplified using a polymerase chain reaction (PCR) and identified through direct Sanger sequencing. Additionally, the mtDNA copy number in matrilineal relatives in this family was evaluated using quantitative PCR. The sequence analysis of the 22 mt-tRNA genes led to the identification of tRNA 5587T>C (thymine to cytosine) and tRNA 12280A>G (adenine to guanine) mutations. Notably, the heteroplasmic 5587T>C mutation was located at the 3' end of tRNA (position 73), which is highly conserved from bacteria to human mitochondria. In addition, the 12280A>G mutation was revealed to occurs at the dihydrouridine loop of tRNA (position 15) and may decrease the steady-state level of mt-tRNA. As a result, 5587T>C and 12280A>G mutations may lead to the failure of tRNAs metabolism and subsequently cause mitochondrial protein synthesis defects. Molecular analysis revealed that patients carrying the 5587T>C and 12280A>G mutations had a lower copy number of mtDNA compared with a control with hypertension, but without the mutations, suggesting that these mutations may cause mitochondrial dysfunctions that are responsible for hypertension. Therefore, mt-tRNA 5587T>C and tRNA 12280A>G mutations may be involved in the pathogenesis of hypertension in this family.
高血压是一种非常常见的心血管疾病,然而,该疾病背后的分子机制仍知之甚少。最近,越来越多的研究表明,线粒体(mt)DNA突变在高血压的发病机制中起重要作用。本研究报道了一个患有母系遗传高血压的中国家系的临床和分子特征(高血压的外显率为71.4%)。此外,使用聚合酶链反应(PCR)扩增了整个线粒体转移(mt-t)RNA基因组,并通过直接桑格测序进行鉴定。此外,使用定量PCR评估了该家系中母系亲属的mtDNA拷贝数。对22个mt-tRNA基因的序列分析导致鉴定出tRNA 5587T>C(胸腺嘧啶到胞嘧啶)和tRNA 12280A>G(腺嘌呤到鸟嘌呤)突变。值得注意的是,异质性5587T>C突变位于tRNA的3'端(第73位),从细菌到人类线粒体高度保守。此外,12280A>G突变发生在tRNA的二氢尿嘧啶环(第15位),可能会降低mt-tRNA的稳态水平。因此,5587T>C和12280A>G突变可能导致tRNA代谢失败,随后导致线粒体蛋白质合成缺陷。分子分析显示,携带5587T>C和12280A>G突变的患者与未携带这些突变的高血压对照相比,mtDNA拷贝数更低,表明这些突变可能导致与高血压相关的线粒体功能障碍。因此,mt-tRNA 5587T>C和tRNA 12280A>G突变可能参与了这个家系中高血压的发病机制。